NYSE:INSP Inspire Medical Systems (INSP) Stock Price, News & Analysis $61.93 -1.14 (-1.81%) Closing price 09/3/2026 03:58 PM EasternExtended Trading$61.40 -0.53 (-0.85%) As of 08:55 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Inspire Medical Systems Stock (NYSE:INSP) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get INSP alerts:Sign Up Key Stats Today's Range$61.65▼$63.7650-Day Range$44.71▼$64.0852-Week Range$38.91▼$147.03Volume398,852 shsAverage Volume488,933 shsMarket Capitalization$1.79 billionP/E Ratio13.40Dividend YieldN/APrice Target$66.19Consensus RatingHold Company Overview Inspire Medical Systems, Inc. is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices. The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve. The device received FDA approval in 2014 and has since obtained CE mark authorization for marketing in Europe. Inspire collaborates with a network of accredited sleep centers and specialized physicians to identify eligible patients and provide training, support and follow-up care. Founded in 2007 and headquartered in Golden Valley, Minnesota, Inspire Medical Systems serves markets across North America and Europe, with ongoing efforts to expand its commercial footprint in select international regions. The company is led by President and Chief Executive Officer Michael A. Moulder, supported by a management team with deep expertise in medical devices, regulatory affairs and commercial operations. Inspire remains focused on advancing its technology platform through clinical research, product enhancements and expanded physician education programs.AI Generated. May Contain Errors. Read More Inspire Medical Systems Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks63rd Percentile Overall ScoreINSP MarketRank™: Inspire Medical Systems scored higher than 63% of companies evaluated by MarketBeat, and ranked 346th out of 913 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.7 / 5Analyst RatingHold Consensus RatingInspire Medical Systems has received a consensus rating of Hold. The company's average rating score is 2.21, and is based on 2 strong buy ratings, 3 buy ratings, 11 hold ratings, and 3 sell ratings.Upside/DownsideThe consensus price target for Inspire Medical Systems is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageInspire Medical Systems has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Inspire Medical Systems' stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth22.58% Earnings GrowthEarnings for Inspire Medical Systems are expected to grow by 22.58% in the coming year, from $1.24 to $1.52 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Inspire Medical Systems is 13.40, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.28.Price to Earnings Ratio vs. SectorThe P/E ratio of Inspire Medical Systems is 13.40, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 273.30.Price to Earnings Growth RatioInspire Medical Systems has a PEG Ratio of 4.79. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioInspire Medical Systems has a P/B Ratio of 2.17. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Inspire Medical Systems' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted15.47% of the float of Inspire Medical Systems has been sold short.Short Interest Ratio / Days to CoverInspire Medical Systems has a short interest ratio ("days to cover") of 5.2.Change versus previous monthShort interest in Inspire Medical Systems has recently increased by 11.56%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInspire Medical Systems does not currently pay a dividend.Dividend GrowthInspire Medical Systems does not have a long track record of dividend growth. News and Social Media3.4 / 5News Sentiment1.50 News SentimentInspire Medical Systems has a news sentiment score of 1.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Inspire Medical Systems this week, compared to 9 articles on an average week.MarketBeat Follows5 people have added Inspire Medical Systems to their MarketBeat watchlist in the last 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Inspire Medical Systems insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $57,347.00 in company stock.Percentage Held by Insiders2.20% of the stock of Inspire Medical Systems is held by insiders.Percentage Held by Institutions94.91% of the stock of Inspire Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Inspire Medical Systems' insider trading history. Receive INSP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inspire Medical Systems and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INSP Stock News HeadlinesInspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare ConferenceAugust 26, 2026 | globenewswire.comInspire Medical Systems (NYSE:INSP) Insider Sells 963 SharesAugust 12, 2026 | insidertrades.comThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.September 4 at 1:00 AM | Reagan Gold Group (Ad)Inspire Medical Systems (INSP) Q2 2026 Earnings Call TranscriptAugust 10, 2026 | finance.yahoo.com5 Insightful Analyst Questions From Inspire Medical Systems’s Q2 Earnings CallAugust 10, 2026 | msn.comInspire Medical Systems, Inc. 2026 Q2 - Results - Earnings Call PresentationAugust 7, 2026 | seekingalpha.comWhy are Inspire Medical Systems (INSP) shares soaring todayAugust 4, 2026 | msn.comInspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 ResultsAugust 4, 2026 | benzinga.comSee More Headlines INSP Stock Analysis - Frequently Asked Questions How have INSP shares performed this year? Inspire Medical Systems' stock was trading at $92.20 at the beginning of 2026. Since then, INSP shares have decreased by 32.8% and is now trading at $61.93. How were Inspire Medical Systems' earnings last quarter? Inspire Medical Systems, Inc. (NYSE:INSP) posted its quarterly earnings data on Monday, August, 3rd. The company reported $0.14 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.24) by $0.38. The company's quarterly revenue was down 7.6% compared to the same quarter last year. Read the conference call transcript. How will Inspire Medical Systems' stock buyback program work? Inspire Medical Systems' Board of Directors authorized a share repurchase program on Monday, August 11th 2025, which authorizes the company to repurchase $200,000,000 in shares, according to EventVestor. This means that the company could purchase up to 8.6% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's management believes its stock is undervalued. When did Inspire Medical Systems IPO? Inspire Medical Systems (INSP) raised $101 million in an initial public offering on Thursday, May 3rd 2018. The company issued 6,750,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs served as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers. Who are Inspire Medical Systems' major shareholders? Top institutional investors of Inspire Medical Systems include BlackRock Inc. (16.39%), Wellington Management Group LLP (8.24%), California State Teachers Retirement System (4.56%) and Assenagon Asset Management S.A. (3.00%). Insiders that own company stock include Timothy P Herbert, Richard Buchholz, Shawn Mccormick, Jason P Kelly, John Rondoni, Jerry C Griffin, Randy Ban and Myriam Curet. View institutional ownership trends. How do I buy shares of Inspire Medical Systems? Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Inspire Medical Systems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Inspire Medical Systems investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), UnitedHealth Group (UNH), Tesla (TSLA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ). Company Calendar Last Earnings8/03/2026Today9/04/2026Wells Fargo 21st Annual Healthcare Conference9/09/2026Next Earnings (Estimated)11/02/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 INSP's financial health is in the Green zone, according to TradeSmith. INSP has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSE:INSP CIK1609550 Webwww.inspiresleep.com Phone(844) 672-4357FaxN/AEmployees1,333Year Founded2007Price Target and Rating Average Price Target for Inspire Medical Systems$66.19 High Price Target$180.00 Low Price Target$39.00 Potential Upside/Downside+6.9%Consensus RatingHold Rating Score (0-4)2.21 Research Coverage19 Analysts Profitability EPS (Trailing Twelve Months)$4.62 Trailing P/E Ratio13.40 Forward P/E Ratio49.94 P/E Growth4.79Net Income$145.42 million Net Margins15.03% Pretax Margin7.72% Return on Equity8.64% Return on Assets7.45% Debt Debt-to-Equity RatioN/A Current Ratio8.55 Quick Ratio6.16 Sales & Book Value Annual Sales$911.98 million Price / Sales1.96 Cash Flow$2.81 per share Price / Cash Flow22.02 Book Value$28.56 per share Price / Book2.17Miscellaneous Outstanding Shares28,910,000Free Float28,274,000Market Cap$1.79 billion OptionableOptionable Beta0.70 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NYSE:INSP) was last updated on 9/4/2026 by MarketBeat.com Staff. From Our PartnersA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredInside the site of Elon’s next major breakthroughInside an ordinary Fremont, California building, Elon Musk is reportedly developing technology he says could e...Monument Traders Alliance | SponsoredHow Long Does $2.5M Last in Retirement?Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredRickards Predicts: Trump to buy tiny $2 stock?Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...Paradigm Press | SponsoredThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...Porter & Company | SponsoredThree companies about to leapfrog Nvidia [And transform the entire industry]In 1984, a 10000 dollar stake in Apple could have grown to 25 million dollars for early investors who simply g...Eagle Publishing | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inspire Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inspire Medical Systems With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
